Cyteir Therapeutics Historical PE Ratio image   This CYT PE ratio history page last updated 3/18/2024
Cyteir Therapeutics Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2023
11/6/2023
3.00-0.10-0.40NA
Q2 2023
8/7/2023
2.72-0.24-0.96NA
Q1 2023
5/10/2023
2.17-0.35-1.40NA
Q4 2022
3/23/2023
1.79-0.25-1.00NA
Q3 2022
11/7/2022
1.75-0.31-1.24NA
Q2 2022
8/8/2022
2.58-0.34-1.36NA
Q1 2022
5/5/2022
2.02-0.40-1.60NA
Q4 2021
3/16/2022
3.59-0.34-1.36NA
Q3 2021
11/12/2021
16.46-0.33-1.32NA
Q2 2021
8/9/2021
21.37-4.83-19.32NA
Q3 2015
10/22/2015
74.400.903.6020.7
Q2 2015
7/16/2015
60.410.813.2418.6
Q1 2015
4/16/2015
54.780.823.2816.7
Q4 2014
1/27/2015
44.000.662.6416.7
Q3 2014
10/16/2014
43.950.742.9614.8
Q2 2014
7/17/2014
51.521.716.847.5
Q1 2014
4/22/2014
49.161.425.688.7
Q4 2013
1/30/2014
44.211.154.609.6
Q3 2013
10/17/2013
43.211.345.368.1
Q2 2013
7/18/2013
39.810.813.2412.3
Q1 2013
4/18/2013
36.460.732.9212.5
Q4 2012
1/31/2013
36.650.722.8812.7
Q3 2012
10/18/2012
33.100.913.649.1
Q2 2012
7/19/2012
32.401.556.205.2
Q1 2012
4/19/2012
31.600.572.2813.9
Cyteir Therapeutics PE History Chart
PeriodPriceGAAPTTMPE
Q3 2023
11/6/2023
3.00-0.10-0.69NA
Q2 2023
8/7/2023
2.72-0.24-1.15NA
Q1 2023
5/10/2023
2.17-0.35-1.25NA
Q4 2022
3/23/2023
1.79-0.25-0.90NA
Q3 2022
11/7/2022
1.75-0.31-1.05NA
Q2 2022
8/8/2022
2.58-0.34-1.08NA
Q1 2022
5/5/2022
2.02-0.40-5.90NA
Q4 2021
3/16/2022
3.59-0.34-4.60NA
Q3 2021
11/12/2021
16.46-0.33-3.45NA
Q2 2021
8/9/2021
21.37-4.83-2.30NA
Q3 2015
10/22/2015
74.400.903.1923.3
Q2 2015
7/16/2015
60.410.813.0319.9
Q1 2015
4/16/2015
54.780.823.9313.9
Q4 2014
1/27/2015
44.000.664.539.7
Q3 2014
10/16/2014
43.950.745.028.8
Q2 2014
7/17/2014
51.521.715.629.2
Q1 2014
4/22/2014
49.161.424.7210.4
Q4 2013
1/30/2014
44.211.154.0311.0
Q3 2013
10/17/2013
43.211.343.6012.0
Q2 2013
7/18/2013
39.810.813.1712.6
Q1 2013
4/18/2013
36.460.733.919.3
Q4 2012
1/31/2013
36.650.723.759.8
Q3 2012
10/18/2012
33.100.91NANA
Q2 2012
7/19/2012
32.401.55NANA
Q1 2012
4/19/2012
31.600.57NANA
Quotes delayed 20 minutes

Email EnvelopeFree CYT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Cyteir Therapeutics (CYT) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

CYTH PE Ratio History
CYTK PE Ratio History
DARE PE Ratio History
DAWN PE Ratio History
DBTX PE Ratio History
DCGO PE Ratio History
DCPH PE Ratio History
DCTH PE Ratio History
DERM PE Ratio History
DFFN PE Ratio History
How should the CYT historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Cyteir Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this CYT Historical PE Ratio page.

What is the average historical PE for CYT based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The CYT historical PE ratio using the annualized quarterly earnings method works out to 12.5.

What is the average historical PE for CYT based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The CYT historical PE ratio using the TTM earnings method works out to 12.5.

On this page we presented the Cyteir Therapeutics Historical PE Ratio information for Cyteir Therapeutics' stock. The average CYT historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 12.5. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average CYT historical PE based on this TTM earnings result method is 12.5. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this CYT historical PE result, against the recent PE: when this page was posted on 3/15/2024, the most recent closing price for CYT had been 3.02, and the most recent quarterly earnings result, annualized, was 3.6. Meanwhile, the most recent TTM earnings summed to 3.19. From these numbers, we calculate the recent CYT PE on 3/15/2024 based on annualized quarterly EPS was 0.8. Based on CYT's history, that recent PE is low relative to the historical average, with the recent PE 93.6% lower than the historical average PE across our data set for Cyteir Therapeutics. Looking at the recent CYT PE on 3/15/2024 based on TTM EPS, we calculate the ratio at 0.9. Based on CYT's history, that recent PE is low relative to the historical average, with the recent PE 92.8% lower than the average PE across our Cyteir Therapeutics data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on CYT or any other given stock, valuation analysis for CYT can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Cyteir Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CYT. Thanks for visiting, and the next time you need to research CYT Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: SPDW Dividend History, EWM Historical Stock Prices, Funds Holding BAOB.

 

Cyteir Therapeutics Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.